PHK
CORT icon

Point72 Hong Kong’s Corcept Therapeutics CORT Stock Holding History

Point72 Hong Kong’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,027
Closed -$65.8K – 584
2023
Q4 		$65.8K Buy
+2,027
New +$55.7K ﹤0.01% 511
2022
Q2 		– Sell
-9,022
Closed -$203K – 1989
2022
Q1 		$203K Buy
9,022
+1,315
+17% +$28K 0.01% 966
2021
Q4 		$153K Buy
7,707
+5,695
+283% +$116K 0.01% 1077
2021
Q3 		$40K Sell
2,012
-1,414
-41% -$29.6K ﹤0.01% 1577
2021
Q2 		$75K Buy
3,426
+2,639
+335% +$58.7K ﹤0.01% 1383
2021
Q1 		$19K Sell
787
-993
-56% -$26.5K ﹤0.01% 1482
2020
Q4 		$47K Buy
+1,780
New +$37.5K ﹤0.01% 1237
2020
Q2 		– Sell
-249
Closed -$3K – 1172
2020
Q1 		$3K Buy
+249
New +$3.08K ﹤0.01% 825

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Point72 Hong Kong's CORT Position: Q1 2024 in Review

Point72 Hong Kong sold out of Corcept Therapeutics (CORT) in Q1 2024, closing a stake of 2,027 shares — an estimated $65.8K sold.

Point72 Hong Kong first reported a position in CORT in Q1 2020 and held it in 8 quarters. The position peaked at $203K in Q1 2022. 287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

  • Point72 Hong Kong reported no remaining Corcept Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 2,027 Corcept Therapeutics shares in Q1 2024, an estimated $65.8K.
  • Point72 Hong Kong first reported a position in Corcept Therapeutics in Q1 2020 and held it in 8 quarters.
  • Point72 Hong Kong's Corcept Therapeutics position peaked at $203K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.